2026-09-17T15:43:56.029Z / 路透社
作者：艾哈迈德·阿布勒·埃恩
2026年9月17日 世界标准时间15:43，29分钟前更新
华盛顿特区医保与医疗救助服务中心负责人穆罕默德·奥兹博士、美国卫生与公众服务部部长小罗伯特·F·肯尼迪，以及美国总统唐纳德·特朗普在华盛顿白宫校区某礼堂一场讨论医疗保健成本与可负担性的活动上站立聆听海蒂·奥弗顿发言，…… 购买授权，打开新标签页查看更多。
（路透社华盛顿9月17日电）美国参议院卫生委员会将于下周为唐纳德·特朗普总统提名的食品药品监督管理局（FDA）负责人人选海蒂·奥弗顿博士举行确认听证会，该委员会周四表示。
美国参议院卫生、教育、劳工与养老金委员会在一份声明中称，听证会将于9月24日举行。特朗普于8月提名这位白宫政策助手奥弗顿，希望借助这位“美国优先”盟友的力量，整顿这家因人员流失、士气低落以及在疫苗、堕胎药和药品审批问题上的争端而陷入困境的机构。
用每日案卷新闻简报将最新法律新闻直接发送到您的收件箱，开启您的清晨。 在此注册。
广告 · 滚动继续浏览
举报广告！
如果参议院确认其提名，奥弗顿将接手过去一年流失超过3000名员工的FDA，其中包括部门负责人，该机构正面临着重建行业和公共卫生团体信心的压力。
这家负责监管和批准所有药品、治疗手段与疫苗的机构，一直面临着变得过于政治化的担忧。
特朗普此前的FDA局长马蒂·马卡里在任13个月后于今年5月辞职，此前他与白宫官员在调味电子烟、一项停滞的堕胎药安全研究以及与Replimune、Sarepta和Moderna等制药商就挽救生命的药物和疫苗审评问题公开存在分歧。
广告 · 滚动继续浏览
奥弗顿是一名预防医学科医生，现任白宫国内政策委员会副主任，此前曾在保守派智库“美国优先政策研究所”任职。
她的提名正值特朗普政府官员就包括自闭症与疫苗以及堕胎药在内的一系列有争议问题采取新行动之际。
她在上个月的一场白宫活动上发表了讲话，当时特朗普签署了一项新的行政令，呼吁大幅缩减全国儿童疫苗接种计划，并将麻疹、腮腺炎和风疹（MMR）疫苗拆分为三针单独接种，这一举措迅速遭到了医生和疫苗制造商的反对。
本届政府正在解决联邦政府内部的卫生岗位空缺积压问题。参议院上月确认埃丽卡·施瓦茨博士担任疾控中心主任，参议院各委员会本周还就其他空缺的高级职位举行了确认听证会，包括卫生部副部长和卫生局局长。
blob:https://www.reuters.com/8f24d233-5a19-4683-9a06-289b3909cc1f
举报广告！
艾哈迈德·阿布勒·埃恩 报道；妮娅·威廉姆斯 编辑
我们的准则：汤森路透信任原则。
US Senate panel sets hearing for Trump’s FDA pick
2026-09-17T15:43:56.029Z / Reuters
By Ahmed Aboulenein
September 17, 2026 3:43 PM UTC Updated 29 mins ago
Centre for Medicare & Medicaid Services Administrator Dr Mehmet Oz, U.S. Health and Human Services Secretary Robert F. Kennedy Jr., and U.S. President Donald Trump stand as Heidi Overton speaks during an event to deliver remarks about health care costs and affordability from an auditorium on the White House campus in Washington,… Purchase Licensing Rights, opens new tabRead more
WASHINGTON, Sept 17 (Reuters) – The U.S. Senate health committee will hold a confirmation hearing next week for Dr. Heidi Overton, President Donald Trump’s pick to lead the embattled Food and Drug Administration, the panel said on Thursday.
The hearing will take place on September 24, the Senate Health, Education, Labor, and Pensions Committee said in a statement. Trump nominated Overton, a White House policy aide, in August, turning to an “America First” ally to steady an agency shaken by staff losses, low morale and fights over vaccines, the abortion pill and drug approvals.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Advertisement · Scroll to continue
Report Ad!
If the Senate confirms her, Overton will take over an FDA that has lost more than 3,000 staff over the past year, including division heads, and is under pressure to rebuild confidence among industry and public-health groups.
The agency, which is responsible for regulating and approving all drugs, treatments and vaccines, has faced concerns it has become too political.
Trump’s previous FDA commissioner, Marty Makary, resigned in May after 13 months in the job following clashes with White House officials over flavored vapes, a stalled abortion-pill safety study and public disagreements with drugmakers such as Replimune, Sarepta and Moderna over reviews of potentially lifesaving medicines and vaccines.
Advertisement · Scroll to continue
Overton, a preventive medicine physician by training who serves as deputy director of the White House Domestic Policy Council, previously worked at the America First Policy Institute, a conservative think tank.
Her nomination coincides with new efforts by Trump health officials to take action on a number of controversial issues, including autism and vaccines as well as the abortion pill.
She spoke at a White House event last month at which Trump signed a new executive order calling for significantly cutting back the national childhood vaccination schedule and splitting the measles, mumps and rubella (MMR) vaccine into three separate shots, a move physicians and vaccine makers swiftly rejected.
The administration is tackling a backlog of health vacancies across government. The Senate confirmed Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention last month, and Senate panels have held confirmation hearings this week for other vacant top posts including deputy health secretary and surgeon general.
blob:https://www.reuters.com/8f24d233-5a19-4683-9a06-289b3909cc1f
Reporting by Ahmed Aboulenein; Editing by Nia Williams
Our Standards: The Thomson Reuters Trust Principles.
发表回复